Related Experiment Video
Updated: May 5, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
The Society of Thoracic Surgeons 2024 Risk Models for Lung Cancer Resection: Continued Refinement and Improved
Betty C Tong1, Levi N Bonnell2, Robert H Habib2
1Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Duke University Medical Center; Durham, North Carolina.
This study refined risk models for pulmonary resection in cancer patients using updated data. The new models offer improved accuracy and broader applicability for predicting patient outcomes after surgery.
Area of Science:
- Thoracic surgery
- Cardiothoracic surgery
- Surgical oncology
Background:
- The Society of Thoracic Surgeons (STS) General Thoracic Surgery Database (GTSD) has been instrumental in developing risk models for pulmonary resection in cancer patients.
- This study aimed to refine existing risk models by utilizing a more contemporary and inclusive patient cohort.
Purpose of the Study:
- To develop and validate updated risk prediction models for operative mortality, major morbidity, and composite morbidity or mortality following pulmonary resection for cancer.
- To improve the accuracy and applicability of risk models by incorporating a broader range of patient data and including nonelective operations.
Main Methods:
- Utilized data from adult patients undergoing pulmonary resection for cancer between 2015 and 2022 from the STS GTSD.
- Included nonelective operations in the analysis, a departure from previous models.
- Developed separate logistic regression models for operative mortality, major morbidity, and composite morbidity or mortality, validated using 9-fold cross-validation.
Main Results:
- Included 140,927 patients from 337 centers; operative mortality was 1.1%, major morbidity 7.3%, and composite morbidity or mortality 7.6%.
- Identified novel predictors such as interstitial lung disease, diffusing capacity of lung for carbon monoxide, and payer status.
- Achieved superior discrimination compared to previous STS models for operative mortality (C-statistic = 0.80) and composite morbidity or mortality (C-statistic = 0.70).
Conclusions:
- Pulmonary resection for cancer continues to have low rates of major morbidity and operative mortality within the STS GTSD cohort.
- The newly derived risk models demonstrate enhanced performance, broader real-world applicability, and clinical validity compared to prior models.
More Related Videos
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024